Skip to main content
Clinical Trials/NCT02572063
NCT02572063TerminatedNot Applicable

Omics4Aging: Stratification of Frailty Population Based on Nutrients Profiling and Metabolic Profiling at Baseline

Société des Produits Nestlé (SPN)1 site in 1 country20 target enrollmentStarted: November 15, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Comparison of Metabonomics, at baseline, among frail population.

Study Overview

Brief Summary

The overall objective of the study is to stratify a frailty population based on nutrients profiling (amino acids, vitamins, minerals, fatty acids) and metabolic profiling (low molecular weight metabolites in urine and plasma) at baseline.

Detailed Description

This exploratory study will investigate ways to better characterize the frailty phenotype by a combination of i) geriatric assessment (here only: frailty criteria according to Fried), ii) clinical surrogate markers (including those of inflammation), iii) body composition, iv) nutritional profiling, v) metabolite profiling using a metabolomics approaches.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
65 Years to 79 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Unless otherwise specified, subjects who fulfill all of the following will be included:
  • Male or female between the ages of 65 and 79 years old
  • Three or more Fried Frailty Criteria (as diagnosed by investigator)
  • Informed consent obtained

Exclusion Criteria

  • Any of the following criteria would render a subject ineligible for inclusion:
  • Dementia (previously diagnosed by general practitioner)
  • Hb1c (glycate Haemoglobin) >7.5% (>58 mmol/mol).
  • End stage disease (1 year after last chemotherapy treatment for cancer)
  • Drug abuse (alcohol - assessed by investigator)
  • Medications: no antibiotic treatment (for at least 4 weeks), immune suppressants, and or chronic use of corticosteroids
  • Currently participating or having participated in another clinical or nutritional intervention trial during the last 3 month
  • Chronic active inflammatory disease (e.g. rheumatoid arthritis, vasculitis, lupus erythematosus and Crohn's disease)
  • Chronic Active hepatitis
  • Kidney failure in Dialysis treatment
  • Any other condition that in the judgment of the lead investigator would not allow the subject to complete the study protocol

Outcomes

Primary Outcomes

Comparison of Metabonomics, at baseline, among frail population.

Time Frame: 1 year

Analysis of Metabolites in blood

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Omics4Aging: Stratification of Frailty... | Clinical Trial